The fully linked HTML version of this article has now been published.
Development ePress online publication date 19 Oct 2005
doi: 10.1242/dev.02088
Research article
Mice deficient in Ext2 lack heparan sulfate and develop exostoses
Dominique Stickens,
Beverly M. Zak,
Nathalie Rougier,
Jeffrey D. Esko,
and
Zena Werb*
* Author for correspondence (e-mail: zena{at}itsa.ucsf.edu)
Hereditary multiple exostoses (HME) is a genetically heterogeneous human disease characterized by the development of bony outgrowths near the ends of long bones. HME results from mutations in EXT1 and EXT2, genes that encode glycosyltransferases that synthesize heparan sulfate chains. To study the relationship of the disease to mutations in these genes, we generated Ext2-null mice by gene targeting. Homozygous mutant embryos developed normally until embryonic day 6.0, when they became growth arrested and failed to gastrulate, pointing to the early essential role for heparan sulfate in developing embryos. Heterozygotes had a normal lifespan and were fertile; however, analysis of their skeletons showed that about one-third of the animals formed one or more ectopic bone growths (exostoses). Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage. These changes were not attributable to a defect in hedgehog signaling, suggesting that they arise from deficiencies in other heparan sulfate-dependent pathways. The finding that haploinsufficiency triggers abnormal cartilage differentiation gives insight into the complex molecular mechanisms underlying the development of exostoses.
This article has been cited by other articles:
|
|
|
|
 
S. Nadanaka and H. Kitagawa
Heparan Sulphate Biosynthesis and Disease
J. Biochem.,
July 1, 2008;
144(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. K. Deirmengian, N. M. Hebela, M. O'Connell, D. L. Glaser, E. M. Shore, and F. S. Kaplan
Proximal Tibial Osteochondromas in Patients with Fibrodysplasia Ossificans Progressiva
J. Bone Joint Surg. Am.,
February 1, 2008;
90(2):
366 - 374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Busse, A. Feta, J. Presto, M. Wilen, M. Gronning, L. Kjellen, and M. Kusche-Gullberg
Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation
J. Biol. Chem.,
November 9, 2007;
282(45):
32802 - 32810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E. Johnson, B. E. Crawford, M. Stavridis, G. ten Dam, A. L. Wat, G. Rushton, C. M. Ward, V. Wilson, T. H. van Kuppevelt, J. D. Esko, et al.
Essential Alterations of Heparan Sulfate During the Differentiation of Embryonic Stem Cells to Sox1-Enhanced Green Fluorescent Protein-Expressing Neural Progenitor Cells
Stem Cells,
August 1, 2007;
25(8):
1913 - 1923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kobayashi, H. Habuchi, K. Tamura, H. Ide, and K. Kimata
Essential Role of Heparan Sulfate 2-O-Sulfotransferase in Chick Limb Bud Patterning and Development
J. Biol. Chem.,
July 6, 2007;
282(27):
19589 - 19597.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Koyama, B. Young, M. Nagayama, Y. Shibukawa, M. Enomoto-Iwamoto, M. Iwamoto, Y. Maeda, B. Lanske, B. Song, R. Serra, et al.
Conditional Kif3a ablation causes abnormal hedgehog signaling topography, growth plate dysfunction, and excessive bone and cartilage formation during mouse skeletogenesis
Development,
June 1, 2007;
134(11):
2159 - 2169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Habuchi, N. Nagai, N. Sugaya, F. Atsumi, R. L. Stevens, and K. Kimata
Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 Exhibit Defective Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic Lethality
J. Biol. Chem.,
May 25, 2007;
282(21):
15578 - 15588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al.
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
J. Cell Biol.,
May 7, 2007;
177(3):
539 - 549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kitagawa, T. Izumikawa, S. Mizuguchi, K. Dejima, K. H. Nomura, N. Egusa, F. Taniguchi, J.-i. Tamura, K. Gengyo-Ando, S. Mitani, et al.
Expression of rib-1, a Caenorhabditis elegans Homolog of the Human Tumor Suppressor EXT Genes, Is Indispensable for Heparan Sulfate Synthesis and Embryonic Morphogenesis
J. Biol. Chem.,
March 16, 2007;
282(11):
8533 - 8544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Voglmeir, R. Voglauer, and I. B. H. Wilson
XT-II, the Second Isoform of Human Peptide-O-xylosyltransferase, Displays Enzymatic Activity
J. Biol. Chem.,
March 2, 2007;
282(9):
5984 - 5990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Lum, J. Tan, S. D. Rosen, and Z. Werb
Gene Trap Disruption of the Mouse Heparan Sulfate 6-O-Endosulfatase Gene, Sulf2
Mol. Cell. Biol.,
January 15, 2007;
27(2):
678 - 688.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Pan, A. Woodbury, J. D. Esko, K. Grobe, and X. Zhang
Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development
Development,
December 15, 2006;
133(24):
4933 - 4944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. McDowell, B. A. Frazier, D. R. Studelska, K. Giljum, J. Chen, J. Liu, K. Yu, D. M. Ornitz, and L. Zhang
Inhibition or Activation of Apert Syndrome FGFR2 (S252W) Signaling by Specific Glycosaminoglycans
J. Biol. Chem.,
March 17, 2006;
281(11):
6924 - 6930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Izumikawa, N. Egusa, F. Taniguchi, K. Sugahara, and H. Kitagawa
Heparan Sulfate Polymerization in Drosophila
J. Biol. Chem.,
January 27, 2006;
281(4):
1929 - 1934.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
